» Articles » PMID: 20086229

Recurrent Moderate Hypoglycemia Ameliorates Brain Damage and Cognitive Dysfunction Induced by Severe Hypoglycemia

Overview
Journal Diabetes
Specialty Endocrinology
Date 2010 Jan 21
PMID 20086229
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Although intensive glycemic control achieved with insulin therapy increases the incidence of both moderate and severe hypoglycemia, clinical reports of cognitive impairment due to severe hypoglycemia have been highly variable. It was hypothesized that recurrent moderate hypoglycemia preconditions the brain and protects against damage caused by severe hypoglycemia.

Research Design And Methods: Nine-week-old male Sprague-Dawley rats were subjected to either 3 consecutive days of recurrent moderate (25-40 mg/dl) hypoglycemia (RH) or saline injections. On the fourth day, rats were subjected to a hyperinsulinemic (0.2 units x kg(-1) x min(-1)) severe hypoglycemic ( approximately 11 mg/dl) clamp for 60 or 90 min. Neuronal damage was subsequently assessed by hematoxylin-eosin and Fluoro-Jade B staining. The functional significance of severe hypoglycemia-induced brain damage was evaluated by motor and cognitive testing.

Results: Severe hypoglycemia induced brain damage and striking deficits in spatial learning and memory. Rats subjected to recurrent moderate hypoglycemia had 62-74% less brain cell death and were protected from most of these cognitive disturbances.

Conclusions: Antecedent recurrent moderate hypoglycemia preconditioned the brain and markedly limited both the extent of severe hypoglycemia-induced neuronal damage and associated cognitive impairment. In conclusion, changes brought about by recurrent moderate hypoglycemia can be viewed, paradoxically, as providing a beneficial adaptive response in that there is mitigation against severe hypoglycemia-induced brain damage and cognitive dysfunction.

Citing Articles

Enhancing severe hypoglycemia prediction in type 2 diabetes mellitus through multi-view co-training machine learning model for imbalanced dataset.

Agraz M, Deng Y, Karniadakis G, Mantzoros C Sci Rep. 2024; 14(1):22741.

PMID: 39349500 PMC: 11444036. DOI: 10.1038/s41598-024-69844-z.


Hypoglycemia and Alzheimer Disease Risk: The Possible Role of Dasiglucagon.

Ali N, Al-Kuraishy H, Al-Gareeb A, Hadi N, Assiri A, Alrouji M Cell Mol Neurobiol. 2024; 44(1):55.

PMID: 38977507 PMC: 11230952. DOI: 10.1007/s10571-024-01489-y.


Case report: Fatal insulin overdose in a dog with type 1 diabetes mellitus-characteristics and successful management.

Park J, An J, Kim S, Choi H, Kim T, Oh Y Front Vet Sci. 2023; 10:1255701.

PMID: 38026640 PMC: 10644660. DOI: 10.3389/fvets.2023.1255701.


Metabolic Profile of Alzheimer's Disease: Is 10-Hydroxy-2-decenoic Acid a Pertinent Metabolic Adjuster?.

Gong Y, Luo H, Li Z, Feng Y, Liu Z, Chang J Metabolites. 2023; 13(8).

PMID: 37623897 PMC: 10456792. DOI: 10.3390/metabo13080954.


Alpha cell receptor for advanced glycation end products associate with glucagon expression in type 1 diabetes.

Leung S, Lenchik N, Mathews C, Pugliese A, McCarthy D, Le Bagge S Sci Rep. 2023; 13(1):12948.

PMID: 37558746 PMC: 10412557. DOI: 10.1038/s41598-023-39243-x.


References
1.
Dagogo-Jack S, Rattarasarn C, Cryer P . Reversal of hypoglycemia unawareness, but not defective glucose counterregulation, in IDDM. Diabetes. 1994; 43(12):1426-34. DOI: 10.2337/diab.43.12.1426. View

2.
. Hypoglycemia in the Diabetes Control and Complications Trial. The Diabetes Control and Complications Trial Research Group. Diabetes. 1997; 46(2):271-86. View

3.
Perantie D, Wu J, Koller J, Lim A, Warren S, Black K . Regional brain volume differences associated with hyperglycemia and severe hypoglycemia in youth with type 1 diabetes. Diabetes Care. 2007; 30(9):2331-7. DOI: 10.2337/dc07-0351. View

4.
McNay E, Sherwin R . Effect of recurrent hypoglycemia on spatial cognition and cognitive metabolism in normal and diabetic rats. Diabetes. 2004; 53(2):418-25. DOI: 10.2337/diabetes.53.2.418. View

5.
Jacobson A, Musen G, Ryan C, Silvers N, Cleary P, Waberski B . Long-term effect of diabetes and its treatment on cognitive function. N Engl J Med. 2007; 356(18):1842-52. PMC: 2701294. DOI: 10.1056/NEJMoa066397. View